Journal article · 2024 · Open access

Transformative Role of Artificial Intelligence in the Pharmaceutical Sector

Balisa Mosisa Ejeta, Malay K Das, Sanjoy Das, Fetene Fufa Bekere, Dubom Tayeng

Journal of Angiotherapy, 8(9), 1–8 · Published 1 September 2024 · DOI 10.25163/angiotherapy.899933

Free PDFView at the publisherCite this paper

In brief

“Transformative Role of Artificial Intelligence in the Pharmaceutical Sector” is a 2024 journal article by Balisa Mosisa Ejeta and 4 co-authors, published in Journal of Angiotherapy. OpenAlex counts 2 citations as of 15 November 2026. It is open access: the full text is free to read at Journal of Angiotherapy.

Citations
2
Most cited in
2024 (1)
Field-weighted impact
0.26
References
1
Authors
5

Abstract

Background: The pharmaceutical sector is a critical component of healthcare, driving innovation in drug discovery, development, and delivery. With the increasing integration of artificial intelligence (AI), digital health technologies, and biotechnology, the industry is transforming rapidly. This review examines the key areas of the pharmaceutical industry and highlights the growing impact of AI in enhancing various processes, from drug discovery to clinical trials. To explore the applications of AI in drug discovery, development, manufacturing, clinical trials, personalized medicine, and regulatory compliance. This review also addresses the challenges, such as data privacy and interoperability, that accompany the adoption of AI in the pharmaceutical sector. Methods: A comprehensive review of existing literature and case studies on the application of AI in pharmaceutical research and operations was conducted. Key areas of focus include AI's role in predictive analytics, target identification, manufacturing, supply chain management, clinical trial optimization, and pharmacovigilance. Results: AI significantly enhances drug discovery by improving target identification, predictive modeling, and high-throughput screening. It optimizes manufacturing through real-time quality control and process automation. In clinical trials, AI facilitates patient recruitment and adaptive trial designs, while in personalized medicine, it enables biomarker discovery and treatment optimization. AI also supports regulatory compliance through automated monitoring and risk assessment. Conclusion: AI is transforming the pharmaceutical sector, making processes more efficient, precise, and tailored to individual patients. However, challenges such as data privacy, ethical considerations, and interoperability must be addressed to fully harness AI's potential. Standardization and collaboration will be essential in driving the next phase of innovation in pharmaceutical development and healthcare delivery.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ejeta, B. M., Das, M. K., Das, S., Bekere, F. F., & Tayeng, D. (2024). Transformative Role of Artificial Intelligence in the Pharmaceutical Sector. Journal of Angiotherapy, 8(9), 1–8. https://doi.org/10.25163/angiotherapy.899933

MLA 9

Ejeta, Balisa Mosisa, et al. “Transformative Role of Artificial Intelligence in the Pharmaceutical Sector.” Journal of Angiotherapy, vol. 8, no. 9, 2024, pp. 1–8. https://doi.org/10.25163/angiotherapy.899933.

Chicago

Ejeta, Balisa Mosisa, Malay K Das, Sanjoy Das, Fetene Fufa Bekere, and Dubom Tayeng. 2024. “Transformative Role of Artificial Intelligence in the Pharmaceutical Sector.” Journal of Angiotherapy 8 (9): 1–8. https://doi.org/10.25163/angiotherapy.899933.

Harvard

Ejeta, B. M. et al. (2024) ‘Transformative Role of Artificial Intelligence in the Pharmaceutical Sector’, Journal of Angiotherapy, 8(9), pp. 1–8. doi:10.25163/angiotherapy.899933.

IEEE

B. M. Ejeta, M. K. Das, S. Das, F. F. Bekere, and D. Tayeng, “Transformative Role of Artificial Intelligence in the Pharmaceutical Sector,” Journal of Angiotherapy, vol. 8, no. 9, pp. 1–8, 2024, doi: 10.25163/angiotherapy.899933.

BibTeX

@article{ejeta2024transformative,
  title     = {{Transformative Role of Artificial Intelligence in the Pharmaceutical Sector}},
  author    = {Ejeta, Balisa Mosisa and Das, Malay K and Das, Sanjoy and Bekere, Fetene Fufa and Tayeng, Dubom},
  journal   = {Journal of Angiotherapy},
  year      = {2024},
  volume    = {8},
  number    = {9},
  pages     = {1--8},
  doi       = {10.25163/angiotherapy.899933},
  url       = {https://doi.org/10.25163/angiotherapy.899933}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • artificial intelligence
  • pharmaceutical industry
  • drug discovery
  • drug development
  • clinical trials
  • personalized medicine
  • pharmacovigilance
  • pharmaceutical manufacturing

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Ejeta, B. M., Das, M. K., Das, S., Bekere, F. F., & Tayeng, D. (2024). Transformative Role of Artificial Intelligence in the Pharmaceutical Sector. Journal of Angiotherapy, 8(9), 1–8. https://doi.org/10.25163/angiotherapy.899933

How many times has this paper been cited?

2 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Journal of Angiotherapy.

Who wrote this paper?

Balisa Mosisa Ejeta, Malay K Das, Sanjoy Das, Fetene Fufa Bekere, Dubom Tayeng.

What is the DOI of this paper?

10.25163/angiotherapy.899933. The permanent link is https://doi.org/10.25163/angiotherapy.899933.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.